Top-Rated StocksTop-RatedNYSE:PHR Phreesia (PHR) Stock Price, News & Analysis → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free PHR Stock Alerts $22.26 +1.25 (+5.95%) (As of 05/2/2024 ET) Add Compare Share Share Today's Range$21.03▼$22.2750-Day Range$20.47▼$25.6452-Week Range$12.05▼$34.98Volume427,178 shsAverage Volume464,171 shsMarket Capitalization$1.26 billionP/E RatioN/ADividend YieldN/APrice Target$31.62 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Get Phreesia alerts: Email Address Phreesia MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.86 Rating ScoreUpside/Downside42.0% Upside$31.62 Price TargetShort InterestBearish4.10% of Shares Sold ShortDividend StrengthN/ASustainability-0.60Upright™ Environmental ScoreNews Sentiment0.74Based on 5 Articles This WeekInsider TradingSelling Shares$1.91 M Sold Last QuarterProj. Earnings GrowthGrowingFrom ($1.48) to ($1.08) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.53 out of 5 starsMedical Sector94th out of 908 stocksBusiness Services, Not Elsewhere Classified Industry17th out of 91 stocks 4.4 Analyst's Opinion Consensus RatingPhreesia has received a consensus rating of Moderate Buy. The company's average rating score is 2.86, and is based on 12 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoveragePhreesia has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 2.0 Short Interest Percentage of Shares Shorted4.10% of the outstanding shares of Phreesia have been sold short.Short Interest Ratio / Days to CoverPhreesia has a short interest ratio ("days to cover") of 4.6.Change versus previous monthShort interest in Phreesia has recently increased by 6.94%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldPhreesia does not currently pay a dividend.Dividend GrowthPhreesia does not have a long track record of dividend growth. Previous Next 4.2 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScorePhreesia has received a 60.31% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Patient flow management systems", "Health care management software", and "Personal health record software" products. See details.Environmental SustainabilityThe Environmental Impact score for Phreesia is -0.60. Previous Next 2.6 News and Social Media Coverage News SentimentPhreesia has a news sentiment score of 0.74. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.33 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Phreesia this week, compared to 3 articles on an average week.MarketBeat FollowsOnly 2 people have added Phreesia to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Phreesia insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,909,216.00 in company stock.Percentage Held by InsidersOnly 5.80% of the stock of Phreesia is held by insiders.Percentage Held by Institutions92.10% of the stock of Phreesia is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Phreesia are expected to grow in the coming year, from ($1.48) to ($1.08) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Phreesia is -8.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Phreesia is -8.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioPhreesia has a P/B Ratio of 4.92. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad AltimetryUrgent Nvidia WarningCould Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.Click here to access… About Phreesia Stock (NYSE:PHR)Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.Read More PHR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PHR Stock News HeadlinesApril 20, 2024 | insidertrades.comPhreesia, Inc. (NYSE:PHR) Insider Sells $20,839.20 in StockApril 18, 2024 | insidertrades.comAmy Beth Vanduyn Sells 685 Shares of Phreesia, Inc. (NYSE:PHR) StockMay 3, 2024 | Paradigm Press (Ad)Biden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.April 13, 2024 | insidertrades.comJanet Gunzburg Sells 2,768 Shares of Phreesia, Inc. (NYSE:PHR) StockApril 11, 2024 | insidertrades.comPhreesia, Inc. (NYSE:PHR) Insider Sells $38,657.58 in StockApril 11, 2024 | insidertrades.comJanet Gunzburg Sells 2,817 Shares of Phreesia, Inc. (NYSE:PHR) StockMay 1, 2024 | businesswire.comPhreesia's Alicia Cowley and Natasha Vega Named to MM+M's ‘Women to Watch' for 2024April 29, 2024 | businesswire.comPhreesia Sets Release Date for Fiscal First Quarter 2025 ResultsMay 3, 2024 | Paradigm Press (Ad)Biden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.April 27, 2024 | newsweek.comWorld's Best Digital Health Companies 2024 - Medical ManagementApril 12, 2024 | investing.comPhreesia Inc. general counsel sells over $233k in company stockApril 12, 2024 | investing.comPhreesia executive sells over $164,000 in company stockApril 9, 2024 | markets.businessinsider.comTruist Financial Reaffirms Their Buy Rating on Phreesia (PHR)March 25, 2024 | finance.yahoo.comInsider Sell: COO Evan Roberts Sells 25,962 Shares of Phreesia Inc (PHR)March 23, 2024 | investing.comPhreesia executive sells over $700 in company stockMarch 22, 2024 | investing.comPhreesia Inc. SVP sells shares worth over $10,000March 21, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Phreesia (PHR) and OmniAb (OABI)March 19, 2024 | finance.yahoo.comPhreesia Full Year 2024 Earnings: In Line With ExpectationsMarch 19, 2024 | msn.comPhreesia gets new technology chiefMarch 19, 2024 | businesswire.comPhreesia Announces Jack Callahan as New Chief Technology OfficerMarch 18, 2024 | msn.comStock Market News for Mar 18, 2024March 17, 2024 | finance.yahoo.comPhreesia, Inc. (NYSE:PHR) Q4 2024 Earnings Call TranscriptMarch 16, 2024 | seekingalpha.comPhreesia, Inc. (PHR) Q4 2024 Earnings Call TranscriptMarch 15, 2024 | finance.yahoo.comPHR Dec 2024 20.000 putMarch 15, 2024 | finance.yahoo.comPHR Jun 2024 17.500 callMarch 15, 2024 | msn.comParenthood Motivates Workers To Be More Productive, New Report ShowsMarch 15, 2024 | markets.businessinsider.comRBC Capital Reaffirms Their Hold Rating on Phreesia (PHR)See More Headlines Receive PHR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Phreesia and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/14/2024Today5/02/2024Next Earnings (Confirmed)5/30/2024Fiscal Year End1/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Business services, not elsewhere classified Sub-IndustryN/A Current SymbolNYSE:PHR CUSIPN/A CIK1412408 Webwww.phreesia.com Phone(888) 654-7473Fax646-607-1776Employees1,438Year FoundedN/APrice Target and Rating Average Stock Price Target$31.62 High Stock Price Target$40.00 Low Stock Price Target$23.00 Potential Upside/Downside+42.0%Consensus RatingModerate Buy Rating Score (0-4)2.86 Research Coverage14 Analysts Profitability EPS (Most Recent Fiscal Year)($2.52) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-136,880,000.00 Net Margins-38.42% Pretax Margin-37.99% Return on Equity-53.33% Return on Assets-38.04% Debt Debt-to-Equity Ratio0.02 Current Ratio1.78 Quick Ratio1.78 Sales & Book Value Annual Sales$356.30 million Price / Sales3.52 Cash FlowN/A Price / Cash FlowN/A Book Value$4.52 per share Price / Book4.92Miscellaneous Outstanding Shares56,390,000Free Float53,117,000Market Cap$1.26 billion OptionableOptionable Beta0.95 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Chaim Indig (Age 45)Co-Founder, CEO & Director Comp: $515kMr. Evan Roberts (Age 45)Co-Founder & COO Comp: $400kMr. David Linetsky (Age 44)Senior Vice President of Life Sciences Comp: $551.64kMr. Balaji Gandhi (Age 50)Chief Financial Officer Ms. Janet M. Gunzburg (Age 58)VP, Principal Accounting Officer & Controller Mr. Jack CallahanChief Technology OfficerMs. Allison C. Hoffman (Age 53)General Counsel & Secretary Comp: $418.96kMs. Maureen McKinneyVice President of Corporate CommunicationsMs. Kharen HauckVice President of MarketingMs. Amy Beth VanDuyn (Age 51)Senior Vice President of Human Resources More ExecutivesKey CompetitorsMultiPlanNYSE:MPLNAtriCureNASDAQ:ATRCCullinan OncologyNASDAQ:CGEMWarby ParkerNYSE:WRBYMirum PharmaceuticalsNASDAQ:MIRMView All CompetitorsInsiders & InstitutionsJennison Associates LLCSold 9,045 shares on 5/2/2024Ownership: 0.053%Mirae Asset Global Investments Co. Ltd.Bought 31,925 shares on 5/1/2024Ownership: 0.235%Janet GunzburgSold 286 sharesTotal: $6,006.00 ($21.00/share)Nichols & Pratt Advisers LLP MASold 19,025 shares on 4/29/2024Ownership: 0.022%Peregrine Capital Management LLCSold 3,375 shares on 4/26/2024Ownership: 0.565%View All Insider TransactionsView All Institutional Transactions PHR Stock Analysis - Frequently Asked Questions Should I buy or sell Phreesia stock right now? 14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Phreesia in the last year. There are currently 2 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" PHR shares. View PHR analyst ratings or view top-rated stocks. What is Phreesia's stock price target for 2024? 14 Wall Street analysts have issued twelve-month price objectives for Phreesia's stock. Their PHR share price targets range from $23.00 to $40.00. On average, they predict the company's stock price to reach $31.62 in the next year. This suggests a possible upside of 42.0% from the stock's current price. View analysts price targets for PHR or view top-rated stocks among Wall Street analysts. How have PHR shares performed in 2024? Phreesia's stock was trading at $23.15 at the beginning of the year. Since then, PHR shares have decreased by 3.8% and is now trading at $22.26. View the best growth stocks for 2024 here. When is Phreesia's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 30th 2024. View our PHR earnings forecast. How can I listen to Phreesia's earnings call? Phreesia will be holding an earnings conference call on Thursday, May 30th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link. How were Phreesia's earnings last quarter? Phreesia, Inc. (NYSE:PHR) announced its earnings results on Thursday, March, 14th. The company reported ($0.56) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.58) by $0.02. The firm had revenue of $95 million for the quarter, compared to the consensus estimate of $93.52 million. Phreesia had a negative trailing twelve-month return on equity of 53.33% and a negative net margin of 38.42%. The company's quarterly revenue was up 24.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.72) earnings per share. What ETFs hold Phreesia's stock? ETFs with the largest weight of Phreesia (NYSE:PHR) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Fidelity Digital Health ETF (FDHT), Fidelity Disruptive Medicine ETF (FMED), Jacob Forward ETF (JFWD) and iShares U.S. Healthcare Providers ETF (IHF).Ranger Equity Bear ETF (HDGE). What guidance has Phreesia issued on next quarter's earnings? Phreesia updated its FY 2025 earnings guidance on Thursday, March, 14th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $424.0 million-$434.0 million, compared to the consensus revenue estimate of $428.1 million. What is Chaim Indig's approval rating as Phreesia's CEO? 172 employees have rated Phreesia Chief Executive Officer Chaim Indig on Glassdoor.com. Chaim Indig has an approval rating of 73% among the company's employees. What other stocks do shareholders of Phreesia own? Based on aggregate information from My MarketBeat watchlists, some companies that other Phreesia investors own include Fastly (FSLY), Zscaler (ZS), Okta (OKTA), DocuSign (DOCU), HealthEquity (HQY), Block (SQ), Appian (APPN), Walt Disney (DIS), Globant (GLOB) and Invitae (NVTA). When did Phreesia IPO? Phreesia (PHR) raised $127 million in an initial public offering on Thursday, July 18th 2019. The company issued 7,800,000 shares at $15.00-$17.62 per share. J.P. Morgan, Wells Fargo Securities, William Blair, Allen & Company and Piper Jaffray served as the underwriters for the IPO. Who are Phreesia's major shareholders? Phreesia's stock is owned by many different retail and institutional investors. Top institutional shareholders include Peregrine Capital Management LLC (0.56%), Mirae Asset Global Investments Co. Ltd. (0.24%), Conestoga Capital Advisors LLC (0.14%), Arcadia Investment Management Corp MI (0.14%), Moody National Bank Trust Division (0.13%) and WoodTrust Financial Corp (0.05%). Insiders that own company stock include Allison C Hoffman, Allison C Hoffman, Amy Beth Vanduyn, Balaji Gandhi, Chaim Indig, David Linetsky, Edward L Cahill, Evan Roberts, Gillian Munson, Janet Gunzburg, Mark Douglas Smith, Michael J Davidoff, Michael Weintraub and Randy Rasmussen. View institutional ownership trends. How do I buy shares of Phreesia? Shares of PHR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:PHR) was last updated on 5/3/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldThe AI stock to buy right nowStockEarningsHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceCould Your Accounts Be Frozen?Allegiance GoldUrgent Nvidia WarningAltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmith$5,000 Gold?Stansberry ResearchBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Phreesia, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
